Target Price | $208.00 |
Price | $170.74 |
Potential |
21.82%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Krystal Biotech, Inc. 2025 .
The average Krystal Biotech, Inc. target price is $208.00.
This is
21.82%
register free of charge
$221.00
29.44%
register free of charge
$195.00
14.21%
register free of charge
|
|
A rating was issued by 10 analysts: 10 Analysts recommend Krystal Biotech, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Krystal Biotech, Inc. stock has an average upside potential 2025 of
21.82%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 50.70 | 291.36 |
474.67% | ||
EBITDA Margin | -181.89% | 24.72% |
113.59% | ||
Net Margin | 22.12% | 35.14% |
58.84% |
9 Analysts have issued a sales forecast Krystal Biotech, Inc. 2024 . The average Krystal Biotech, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Krystal Biotech, Inc. EBITDA forecast 2024. The average Krystal Biotech, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Krystal Biotech, Inc. 2024 . The average Krystal Biotech, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 0.39 | 3.56 |
107.10% | 812.82% | |
P/E | 47.96 | |
EV/Sales | 14.86 |
1 Analysts have issued a Krystal Biotech, Inc. forecast for earnings per share. The average Krystal Biotech, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Krystal Biotech, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Krystal Biotech, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.